Spinal Simpicity's Patriot-SI posterior implant system for sacroiliac joint fusion earned FDA 510(k) clearance.
The implant is designed to work in combination with the company's Liberty-SI lateral system, according to a May 1 news release. Patriot-SI is for SI joint fusion in patients with conditions such as sacroiliac disruptions and degenerative sacroiliitis.
"We've already seen excellent patient outcomes with the Liberty-SI Lateral System since its introduction in December 2023," Spinal Simplicity CEO Todd Moseley said in the release. "The Patriot SI technology is constructed intentionally as a cannulated implant, designed for repeatable, reproducible techniques, with the implant traveling directly over the guidewire for precision placement in the SI Joint."
The Patriot-SI system is expected to hit the market in the second quarter of 2024.